RX Braekeveld MB
ActiveFrom the official registers: KBO 8 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
RX Braekeveld MB has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €170,059 and a net result of €84,720. Equity has been shrinking by about 17% per year since 2018. Its solvency ranks better than 34% of 3,024 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
KBO- Status
- Active since 31-03-2018 Normal situation
- Legal form
- Private limited company
- Registered office
- Hubert Frère-Orbanlaan 177, 9000 Gent
- Activity
- Specialist medical practice NACE 86220
- Establishment unit
- 2.388.164.843 9000 Gent, since 01-07-2026
- Financial year end
- 31 December
- Peppol
- Reachable since 27-03-2026
Board and ownership
Board
- Radiology Partners Europe BVDirector · since 19-12-2025
Shareholders
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
Annual accounts 2025
- Gross margin
- €403,511
- ▼ 12.5%
- Turnover
- ≈ €790,000
- estimated
- Profit
- €84,720
- ▼ 39.7%
- Equity
- €170,059
- ▲ 99.3%
- Total assets
- €432,874
- ▼ 29.4%
- Staff
- 3.6 FTE
- ▲ 16.1%
2025 accounts filed 3 days before the deadline
Filed on 28-07-2026at the National Bank
Score breakdownraises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.68, cash €152,314Figures for financial year 2025 (filed on 28-07-2026)Show the evidence
Checked score
Score 2025
94
/ 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 56% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency
64+25
equity 39.3% of total assets
Liquidity
69+22
short-term debt 49.5% · cash 35.2%
Profitability
93-4
return on assets 19.6%
Bankruptcy probability within 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.2%
12-2024: 0.2%● unchanged vs 11-2024
01-2025: 0.2%● unchanged vs 12-2024
02-2025: 0.2%● unchanged vs 01-2025
03-2025: 0.2%● unchanged vs 02-2025
04-2025: 0.2%● unchanged vs 03-2025
05-2025: 0.2%● unchanged vs 04-2025
06-2025: 0.3%▲ +0.1 percentage points vs 05-2025
07-2025: 0.3%● unchanged vs 06-2025highest value
08-2025: 0.1%▼ -0.2 percentage points vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026lowest value
09-2026: < 0.1%● unchanged vs 08-2026lowest value
10-2026: 0.1%▲ +0.1 percentage points vs 09-2026
Credit of up to €15,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.68 (1.2 in 2024), above the usual 1.5. Short-term debt is 49.5% and cash 35.2% of total assets. However, 60.7% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 32% of them on solvency, 50% on liquidity, 51% on profitability and 90% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-07-2026, 3 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
3 days early
2024
16 days early
2023
5 days early
2022
5 days early
2021
99 days late
2020
320 days late
2019
30 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 51 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
Key points
- Positive: Equity rose in 2025from €85,339 to €170,059 ▲ 99.3% View
- Positive: 8 profitable years in a rowprofit 2025: €84,720 8 years View
- New directorlatest change 19-12-2025 · 1 in office 1 joined View
- Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 28-07-2026
- Annual accounts 2024filed on 15-07-2025
- Annual accounts 2023filed on 26-07-2024
- Annual accounts 2022filed on 26-07-2023
Acts in the Belgian Official Gazette
- Registered office · Other addressesact of 17-09-2026
- Resignations & appointmentsact of 25-11-2022
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about RX Braekeveld MB
- What is the company number of RX Braekeveld MB?
- The company number of RX Braekeveld MB is 0695.423.385. The VAT number is the same number with BE in front: BE 0695.423.385.
- Where is RX Braekeveld MB based?
- The registered office is at Hubert Frère-Orbanlaan 177, 9000 Gent.Company details
- What does RX Braekeveld MB do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of RX Braekeveld MB?
- The legal form of RX Braekeveld MB is Private limited company (BV).
- When was RX Braekeveld MB founded?
- RX Braekeveld MB was founded on 31-03-2018.
- Is RX Braekeveld MB still active?
- Yes, RX Braekeveld MB is an active enterprise in the KBO register.
- How many employees does RX Braekeveld MB have?
- RX Braekeveld MB had an average of 3.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of RX Braekeveld MB?
- The turnover in financial year 2025 is ≈ €790,000. This figure is estimated from the gross margin of €403,511 and 40 comparable companies (NACE 862). It probably lies between €530,000 and €1.2m.
- Is RX Braekeveld MB profitable?
- In financial year 2025, RX Braekeveld MB made a profit of €84,720.
- Where can I find the annual accounts of RX Braekeveld MB?
- RX Braekeveld MB filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
- When are the next annual accounts of RX Braekeveld MB due?
- RX Braekeveld MB must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Companies linked to RX Braekeveld MB
Shareholders
Comparable companies
These companies have the same main activity as RX Braekeveld MB: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €301,000 and €735,000, founded between 2015 and 2020.
| Company | Total assets | Gross margin |
|---|---|---|
| RX Braekeveld MB Gent | €432,874 | €403,511 |
| LIFE EXPERT CENTRE Leuven | €465,475 | €353,935 |
| CABINET OPHTALMOLOGIQUE LES MEDECINS ASSOCIES Olne | €625,762 | €487,835 |
| BETER ZIEN Ieper | €694,998 | €324,900 |
| MKA West-Limburg Heusden-Zolder | €707,119 | €392,237 |
| ASSOGYN SINT-TRUIDEN Sint-Truiden | €734,847 | €340,712 |
| Oogcentrum Oudenaarde Oudenaarde | €300,800 | €261,927 |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies See the other companies in the same group.Radiology Partners Europe · 19 companies
See how customers, suppliers and banks see your own company and what to improve first.